Cargando…

Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence

L-citrulline and L-arginine supplementation has been shown to have several beneficial effects on the cardiovascular system. Nitric oxide (NO) protects against the progression of atherosclerosis and is synthesized by nitric oxide synthase (NOS), which converts L-arginine (L-Arg) into L-citrulline (L-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuboi, Tomoe, Maeda, Morihiko, Hayashi, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802914/
https://www.ncbi.nlm.nih.gov/pubmed/29415069
http://dx.doi.org/10.1371/journal.pone.0192252
_version_ 1783298613569388544
author Tsuboi, Tomoe
Maeda, Morihiko
Hayashi, Toshio
author_facet Tsuboi, Tomoe
Maeda, Morihiko
Hayashi, Toshio
author_sort Tsuboi, Tomoe
collection PubMed
description L-citrulline and L-arginine supplementation has been shown to have several beneficial effects on the cardiovascular system. Nitric oxide (NO) protects against the progression of atherosclerosis and is synthesized by nitric oxide synthase (NOS), which converts L-arginine (L-Arg) into L-citrulline (L-Cit). Our previous study revealed that chronic administration of a combination of L-Cit and L- Arg has a better therapeutic effect on high cholesterol-induced atherosclerosis in rabbits. We investigated how L-Arg and L-Cit affect endothelial function, aging and atherosclerosis. Following a 3-day stimulation of human umbilical venous endothelial cells (HUVECs) with high glucose (HG: 22 mM) and L-Arg (300 μM), L-Cit (300 μM) or L-Arg plus L-Cit (LALC: each 150 μM) supplementation, endothelial senescence and function were evaluated. These amino acids were also administered to dyslipidemic type 2 diabetic (ZDFM) rats fed a high cholesterol diet. They were fed L-Arg or L-Cit or LALC for four weeks. Aortic senescence was investigated by measuring senescence-associated ß-galactosidase (SA-ß-gal), telomerase activity, DNA damage and p16(INK4a) protein expression. Only L-Cit and LALC supplementation retarded the HG-induced endothelial senescence, as evaluated by SA-ß-gal activity, a widely used marker of cellular senescence, p16(INK4a) expression, a senescence-related protein, and DNA damage. Under HG conditions, L-Cit and LCLA restored telomerase activity to levels observed under normal glucose (NG) conditions. Under HG conditions, L-Cit decreased ROS production, as measured by CM-H(2)DCFDA and the expression of p67(phox), a major component of NADPH oxidase. Under HG conditions, L-Cit and LALC increased NO production, as measured by DAF-2AM. Endothelial NO synthase (eNOS) and phosphorylated eNOS were decreased under HG conditions and L-Cit and LALC significantly increased these levels. Arginase 2 protein expression increased under the HG conditions, and L-Cit and LALC significantly attenuated this effect. In ZDFM rats, SA-ß-gal activity was detected on the aortic endothelial surface; however, L-Cit and LALC reduced these levels. L-Cit and LALC both decreased the proportion of senescent cells. Furthermore, treatment with LALC for 4 weeks increased plasma NO production. Therefore conclusively, L-citrulline supplementation rescued NO levels better than L-arginine supplementation by inhibiting ROS production and arginase 2 protein expression. Consequently, L-Cit and LCLA supplementation retaeded HG-induced endothelial senescence.
format Online
Article
Text
id pubmed-5802914
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58029142018-02-23 Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence Tsuboi, Tomoe Maeda, Morihiko Hayashi, Toshio PLoS One Research Article L-citrulline and L-arginine supplementation has been shown to have several beneficial effects on the cardiovascular system. Nitric oxide (NO) protects against the progression of atherosclerosis and is synthesized by nitric oxide synthase (NOS), which converts L-arginine (L-Arg) into L-citrulline (L-Cit). Our previous study revealed that chronic administration of a combination of L-Cit and L- Arg has a better therapeutic effect on high cholesterol-induced atherosclerosis in rabbits. We investigated how L-Arg and L-Cit affect endothelial function, aging and atherosclerosis. Following a 3-day stimulation of human umbilical venous endothelial cells (HUVECs) with high glucose (HG: 22 mM) and L-Arg (300 μM), L-Cit (300 μM) or L-Arg plus L-Cit (LALC: each 150 μM) supplementation, endothelial senescence and function were evaluated. These amino acids were also administered to dyslipidemic type 2 diabetic (ZDFM) rats fed a high cholesterol diet. They were fed L-Arg or L-Cit or LALC for four weeks. Aortic senescence was investigated by measuring senescence-associated ß-galactosidase (SA-ß-gal), telomerase activity, DNA damage and p16(INK4a) protein expression. Only L-Cit and LALC supplementation retarded the HG-induced endothelial senescence, as evaluated by SA-ß-gal activity, a widely used marker of cellular senescence, p16(INK4a) expression, a senescence-related protein, and DNA damage. Under HG conditions, L-Cit and LCLA restored telomerase activity to levels observed under normal glucose (NG) conditions. Under HG conditions, L-Cit decreased ROS production, as measured by CM-H(2)DCFDA and the expression of p67(phox), a major component of NADPH oxidase. Under HG conditions, L-Cit and LALC increased NO production, as measured by DAF-2AM. Endothelial NO synthase (eNOS) and phosphorylated eNOS were decreased under HG conditions and L-Cit and LALC significantly increased these levels. Arginase 2 protein expression increased under the HG conditions, and L-Cit and LALC significantly attenuated this effect. In ZDFM rats, SA-ß-gal activity was detected on the aortic endothelial surface; however, L-Cit and LALC reduced these levels. L-Cit and LALC both decreased the proportion of senescent cells. Furthermore, treatment with LALC for 4 weeks increased plasma NO production. Therefore conclusively, L-citrulline supplementation rescued NO levels better than L-arginine supplementation by inhibiting ROS production and arginase 2 protein expression. Consequently, L-Cit and LCLA supplementation retaeded HG-induced endothelial senescence. Public Library of Science 2018-02-07 /pmc/articles/PMC5802914/ /pubmed/29415069 http://dx.doi.org/10.1371/journal.pone.0192252 Text en © 2018 Tsuboi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Tsuboi, Tomoe
Maeda, Morihiko
Hayashi, Toshio
Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence
title Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence
title_full Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence
title_fullStr Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence
title_full_unstemmed Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence
title_short Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence
title_sort administration of l-arginine plus l-citrulline or l-citrulline alone successfully retarded endothelial senescence
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802914/
https://www.ncbi.nlm.nih.gov/pubmed/29415069
http://dx.doi.org/10.1371/journal.pone.0192252
work_keys_str_mv AT tsuboitomoe administrationoflargininepluslcitrullineorlcitrullinealonesuccessfullyretardedendothelialsenescence
AT maedamorihiko administrationoflargininepluslcitrullineorlcitrullinealonesuccessfullyretardedendothelialsenescence
AT hayashitoshio administrationoflargininepluslcitrullineorlcitrullinealonesuccessfullyretardedendothelialsenescence